Docetaxel, Oxaliplatin

DRUG3 trials

Sponsors

Johannes Gutenberg University Mainz, Samsung Medical Center, Korean South West Oncology Group

Conditions

Biliary Tract CancerEsophageal NeoplasmsGastric CancerStomach Neoplasms

Phase 1

Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction

CompletedNCT00374985

Johannes Gutenberg University MainzEsophageal Neoplasms, Stomach Neoplasms

Start: 2005-10-31End: 2013-09-30Updated: 2014-12-02

A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer

CompletedNCT00533533

Samsung Medical CenterGastric Cancer

Start: 2006-01-31End: 2008-06-30Target: 68Updated: 2009-01-14

Phase 2

Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer

Korean South West Oncology GroupBiliary Tract Cancer

Start: 2010-11-30End: 2013-12-31Target: 53Updated: 2011-12-12

Related Papers

Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.

Journal of Clinical Oncology2014-05-20

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction.

2013-02-118 citations